DOI: http://dx.doi.org/10.18203/2349-2902.isj20220329

A clinical study on efficacy of peri-lesional autologous platelet-rich plasma in non-healing ulcers

Raghuveer Chakravarthy Gogineni, Ratta Reddy Bommareddy, Ede Naresh Babu, Mayanam Subhashini, Akula V. S. Jaya Krishnah

Abstract


Background: Non-healing ulcers are a major health problem worldwide and have a great impact at personal, professional, and social levels. They are a major cause of non-traumatic lower limb amputations. The application of autologous Platelet Rich Plasma (PRP) has been a breakthrough in the treatment of non-healing ulcers, as it is an easy and cost-effective procedure, and provides the necessary growth factors that enhance tissue healing. The aim and objective of the study was to test the effectiveness of peri-ulcer autologous platelet-rich plasma injection in chronic non-healing ulcers and to assess the time taken for wound closure.

Methods: This study was conducted on 50 patients during the period of November 2020 to October 2021 from the in-patients of the surgical unit in Dr. PSIMS and RF. Autologous PRP was prepared from whole blood utilizing a rapid, point-of-care system that works on the principle of density gradient centrifugation. Fifty (50) patients with non-healing ulcers of different etiologies, who met the inclusion criteria, were treated with peri-ulcer autologous PRP injections once weekly.

Results: Of the 50 cases 29 were male and 21 were female, the mean age of the patients is 54.48±10.79 years. All the patients showed signs of wound healing with a reduction in wound size, and the mean time duration of ulcer healing was 6.75±1.47 weeks.

Conclusions: This prospective study has demonstrated the potential safety and efficacy of autologous platelet-rich plasma injection for the treatment of chronic non-healing ulcers.


Keywords


Platelet-rich plasma, PRP, Non-healing ulcers, Venous ulcers

Full Text:

PDF

References


Sebastian KMS, Lobato I, Hernandez I. Efficacy and safety of autologous platelet rich plasma for the treatment of vascular ulcers in primary care: phase III study. BMC Fam Pract. 2014;15:211.

Greer N, Foman N, Dorrian J. Advanced wound care therapies for nonhealing diabetic, venous, and arterial ulcers: a systematic review. 2012;09-009.

Sheehan P, Jones P, Caselli A, Giurini JM, Veves AJD. Percent change in wound area of Diabetic foot ulcers over a four-week period is a robust predictor of complete healing in a twelve-week prospective trial. 2003;26(6):1879-82.

Robson MC, Barbul A. Guidelines for the best care of Chronic wounds. Wound repair and regeneration: official publication of the Wound Healing Society [and] the European Tissue Repair Society. 2006;14(6):647-8.

Aminian B SM, Karim-Agahee B, Soveyd M, Om Rani GR. The role of the autologous platelet-derived growth factor in the management of Decubitus ulcer. Arch Iranian Med. 1999;2:98-101.

Steed DL. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcer. Diabetic ulcer study group. Journal of vascular surgery. 1995;21(1):71-8.

Martinez-Zapata MJ, Marti–Carvajal CAJ, Sola I, Exposito JA, Bolibar I, Rodriguez L, et al. Autologous platelet-rich plasma for treating chronic wounds. The Cochrane database of systematic reviews. 2016;(5):Cd006899.

Driver VR, Hanft J, Fylling CP, Deriou JM. A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers. Ostomy/wound management. 2006;52(6):68-70.

Damir AJJ. Recent advances in management of chronic non-healing diabetic foot ulcers. 2011;24(4):2019-23.

Andia I, Abate MJR. Platelet-rich plasma: underlying biology and clinical corelates. 2013;8(5):645-58.

Li L, Chen D, Wang C. Autologous Platelet-rich gel for treatment of diabetic chronic refractory cutaneous ulcers: A prospective, randomized clinical trial. Wound repair and regeneration: official publication of the Wound Healing Society [and] the European Tissue Repair Society. 2015;23(4):495-505.

Ahmed M, Reffat SA. Platelet-rich plasma for the treatment of Clean Diabetic foot ulcers. Annals of vascular surgery. 2017;38:206-11.

Sakata J, Sasaki S. A retrospective, longitudinal study to evaluate healing lower extremity wounds in patients with dibetes mellitus and ischemia using standard protocols of care and platelet-rich plasma gel in a Japanese wound care program. Ostomy/wound management. 2012;58(4):36-49.

Yilmaz S, Aksoy E, Dogansi S. autologous platelet-rich plasma in treatment of chronic venous leg ulcers: A prospective case series. Vascular. 2015;23(6):580-5.

Stacey M, Mata SD, Trengove NJ, Mather CA. Randomised double-blind placebo-controlled trial of topical autologous platelet lysate in venous ulcer healing. European journal of vascular and endovascular surgery. The official journal of the Eurpoean Society for Vascular Surgery. 2000;20(3):296-301.

Crovetti G, Martinelli G, Issi M. Platelet gel for healing cutaneous chronic wounds. Transfusion and apheresis science: official journal of the World Apheresis Association. Official journal of the European Society for Haemapheresis. 2004;30(2):145-51.